Details for Patent: 11,008,289
✉ Email this page to a colleague
Which drugs does patent 11,008,289 protect, and when does it expire?
Patent 11,008,289 protects YUPELRI and is included in one NDA.
This patent has thirty-three patent family members in twenty-one countries.
Summary for Patent: 11,008,289
Title: | Crystalline freebase forms of a biphenyl compound |
Abstract: | The invention provides two crystalline freebase forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piper- idin-4-yl ester. The invention also provides pharmaceutical compositions comprising the crystalline freebase or prepared using the crystalline freebases; processes and intermediates for preparing the crystalline freebases; and methods of using the crystalline freebases to treat a pulmonary disorder. |
Inventor(s): | Woollam; Grahame (Basel, CH) |
Assignee: | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) |
Application Number: | 16/715,225 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,008,289
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Ireland Ltd | YUPELRI | revefenacin | SOLUTION;INHALATION | 210598-001 | Nov 9, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,008,289
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2010273514 | ⤷ Try a Trial | |||
Brazil | 112012000890 | ⤷ Try a Trial | |||
Canada | 2765621 | ⤷ Try a Trial | |||
Canada | 2989129 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |